Clinical trial
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk…
NCT00043472 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00043472 |
|---|---|
| Title | Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk |
| Official title | Prospective Study of Prophylactic Salpingo-Oophorectomy and Longitudinal CA-125 Screening Among Women at Increased Genetic Risk of Ovarian Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Breast Cancer, Ovarian Cancer |
| Enrollment | 40 |
| Start date | Jul 9, 2003 |
| First posted | Aug 9, 2002 |
| Last update posted | Jan 5, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: